Background {#Sec1}
==========

*Salmonella* remains one of the most prevalent foodborne pathogens causing bacterial gastroenteritis \[[@CR1], [@CR2]\]. Infection through contaminated food and water can lead to diarrhea and even death. It has been reported that *Salmonella* species can account for nearly 93.8 million cases of gastroenteritis every year worldwide, resulting in 155,000 deaths \[[@CR3]\]. In China, *Salmonella* spp. are responsible for approximately 22.2% of foodborne diseases, resulting in 9.03 million cases and estimated 800 deaths annually \[[@CR4]\]. Therefore, it is particularly important to further strengthen the surveillance and control of *Salmonella*. As hydrogen sulfide (H~2~S) production is characteristic of these pathogens, H~2~S detection has become a screening method to identify and differentiate *Salmonella* from other intestinal bacteria \[[@CR5]\]. However, H~2~S-negative *Salmonella* isolates have been continuously reported in different countries; thus, one isolate was identified in Kuwait, 10 in United States, 31 in Japan, and 58 in Southeast China \[[@CR6]--[@CR12]\]. In our previous studies, we also identified 43 H~2~S-negative *Salmonella* isolates during national surveillance of salmonellosis in China \[[@CR13]--[@CR15]\]. These results suggest that the occurrence of the atypical H~2~S-negative *Salmonella* variants is growing throughout the world.

Increasing resistance of *Salmonella* to antibiotics, especially high prevalence of multidrug resistance (MDR), is a global concern. In many regions of the world, a high resistance rate to conventional antimicrobial agents has been reported for H~2~S-positive *Salmonella* \[[@CR16]--[@CR19]\]*.* Although H~2~S-negative *Salmonella* isolates may be highly sensitive to a multitude antibiotics owning to H~2~S defending bacteria against oxidative stress imposed by antibiotics \[[@CR20]\], there is increasing evidence that high resistance rate to antibiotics was also observed in many H~2~S-negative *Salmonella* isolates \[[@CR6], [@CR7], [@CR14]\]. Importantly, extended-spectrum cephalosporins and fluoroquinolones have been widely used as alternative agents for treatment of salmonellosis. However, a non-H~2~S-producing *S.* Kentucky isolate had the MDR phenotype, including resistance to ciprofloxacin, whereas non-H~2~S-producing *S*. Infantis and *S*. Typhimurium expressed CMY-2β-lactamase and had reduced susceptibility to cefazolin \[[@CR6], [@CR8]\]. These results may due to different bactericidal mechanisms of various classes of antibiotics. Taken together, it is important to pay more attention on the surveillance of H~2~S-negative *Salmonella*.

*Salmonella* spp. produce H~2~S from various enzymes encoded by different operons, such as *phs* operon, *cysJIH* operon and *asr* operon \[[@CR21]--[@CR23]\]. However, the *phs* operon is essential for this activity in *Salmonella* \[[@CR24]\]. Sakano et al. \[[@CR8]\] detected a nonsense mutation in the *phsA* gene in H~2~S-negative *S.* Infantis and *S.* Typhimurium isolates, and in our previous studies, we found more mutations in the *phsA* gene of H~2~S-negative *S.* Senftenberg, *S.* Choleraesuis, and *S.* Aberdeen \[[@CR13]--[@CR15]\]. These data suggest that the disruption of the *phs* locus is responsible for the lack of H~2~S production and incorrect identification of *Salmonella*. Here, we report the identification of 46 H~2~S-negative *Salmonella* strains during the national surveillance of salmonellosis from 2005 to 2013 in China. Our findings indicate that various serovars of H~2~S-negative *Salmonella* have emerged in China. Therefore, effective measures should be urgently taken to prevent and control further dissemination of H~2~S-negative *Salmonella* in China.

Methods {#Sec2}
=======

Isolation, identification, and serotyping of *Salmonella* strains {#Sec3}
-----------------------------------------------------------------

In this study, *Salmonella* isolates were obtained during national surveillance for salmonellosis in China conducted from 2005 to 2013. Samples were collected in eight cities throughout China (Beijing, Nanjing, Shanghai, Guangzhou, Shenyang, Jinan, Xinjiang, and Yuxi) from various sources, including diarrhea patients, poultry, livestock, vegetables, aquatic products, and water. First, the samples were enriched by culturing in Selenite Brilliant Green broth (CHROMagar, Shanghai, China) at 37 °C for 16--22 h, and then plated on xylose lysine deoxycholate agar (XLD; CHROMagar) and CHROMagar Salmonella medium (CAS; CHROMagar) at 37 °C for 18--24 h. Colonies suspected to be formed by *Salmonella* were serotyped by slide agglutination tests (SSI Diagnostica, Hillerød, Denmark). API 20E test strips (bioMerieux Vitek, Marcy-l'Etoile, France) were used to confirm the identified colonies and examine for the H~2~S-producing phenotype.

Antimicrobial susceptibility testing {#Sec4}
------------------------------------

H~2~S-negative and H~2~S-positive *Salmonella* isolates were tested for sensitivity to 21 antibiotics used commonly in laboratories and hospitals. MICs of 21 antibiotics including amikacin, ampicillin, aztreonam, cefazolin, cefepime, cefoperazone, cefoxitin, ceftazidime, ceftriaxone, chloramphenicol, gentamicin, imipenem, levofloxacin, nitrofurantoin, norfloxacin, piperacillin, tetracycline, ticarcillin, ticarcillin-clavulanic acid, tobramycin, and trimethoprim-sulfamethoxazole were evaluated by the automated broth microdilution method using 96-well microtiter plates (Sensititre; Terk Diagnostic Systems, Thermo Fisher Scientific Inc., Cleveland, OH, USA). The results were interpreted according to the recommendations of the Clinical and Laboratory Standards Institute (CLSI) \[[@CR25]\] and *Escherichia coli* strain ATCC 25922 was used for quality control. Genetic variations related to molecular mechanisms responsible for the resistance to quinolones were examined by PCR. The specific primers were as follows: *gyrA* forward 5′-TTATGCGATGTCGGTCATTGTT-3′ and reverse 5′-TTCACCAGCTCGGCGATT-3′ and *parC* forward 5′-CGTGCGTTGCCGTTTATTG-3′ and reverse 5′-CAACTGATCCAGCGTCGTT-3′.

Multilocus sequence typing analysis {#Sec5}
-----------------------------------

Total DNA was extracted from the identified *Salmonella* isolates using the TIANamp Bacteria DNA kit (Tiangen Biotech, Beijing, China) according to the manufacturer's instruction, and MLST was performed using the protocol described in our previous study \[[@CR13]\]. Sequences of seven housekeeping genes (*aroC*, *dnaN*, *hemD*, *hisD*, *purE*, *sucA*, and *thrA*) were downloaded from the MLST database. The sequences of PCR-amplified products were uploaded to <http://enterobase.warwick.ac.uk/species/senterica/allele_st_search> for comparison and analysis to determine the sequence type (ST).

Pulsed-field gel electrophoresis analysis {#Sec6}
-----------------------------------------

DNA was digested with *Xba*I (Takara, Dalian, Japan) at 37 °C for 3 h and subjected to PFGE according to a standardized protocol \[[@CR26]\]. Then, electrophoresis of the digested DNA was carried out using a CHEF Mapper PFGE system (Bio-Rad, Hercules, CA, USA) in 1% SeaKem agarose and 0.5× Tris-borate-EDTA for 19 h with the following run parameters: 6 V/cm and a linear increase in switching times from 2.16 to 63.8 s. Macrorestriction patterns were compared and analyzed using the BioNumerics Fingerprinting software version 6.0 (Applied-Maths, Sint-Martens-Latem, Belgium). Dendrograms were constructed according to the unweighted pair-group method of arithmetic average (UPGMA), and the Disc coefficient of similarity was determined based on 1.2% position tolerance. *S.* Braenderup H9812 was used as a standard \[[@CR27]\].

Amplification and sequencing of the *Phs* operon {#Sec7}
------------------------------------------------

The *phs* operon containing three open reading frames, designated *phsA*, *phsB*, and *phsC*, which encode thiosulfate reductases catalyze thiosulfate to H~2~S. The *phs* operon (*phsA*, *phsB*, and *phsC*) was amplified by PCR and sequenced by Sangon Biotech. The specific primers were as follows: *phsA1* forward 5′-CGTTGGATGCCTGTTCAG-3′ and reverse 5′-AGGTCGTAGAGCCGATTG-3′, *phsA2* forward5′-CGCCGTTCAACTGATAGA-3′ and reverse 5′-AATGGTGAGCTTCGATCC-3′, *phsA3* forward 5′-CATCGTAGAGCTGTTCATCA-3′ and reverse 5′-CATGTGCGTGTTCAGGAA-3′, *phsB* forward 5′-CAAGCATGAGCAGCACCAC-3′ and reverse 5′-ATGAGGGAGGAGGGAACCAT-3′, and *phsC* forward 5′-GATGGTCTCTATTTGCCGTTCT-3′ and reverse 5′-GGTGCTGCTCATGCTTGTT-3′.

The PCR amplification conditions were as follows: PCR conditions were as follows: 95 °C for 5 min; 30 cycles of 95 °C for 30 s, 57 °C for 40 s, and 72 °C for 45 s; and 72 °C for 7 min, using Ex Taq DNA polymerase (TaKaRa/Clontech). The results were imported into DNAman 6.0, and genetic differences were detected using MEGA version 7.0. Reference strains for *phs* operon sequence analysis are listed in Additional file [1](#MOESM1){ref-type="media"}: Table S1. For *S.* Derby and *S.* Meleagridis, the reference strains (*S.* Derby str. 91,780 and *S.* Meleagridis str. SH10SF424--1) were of the H~2~S-positive phenotype identified in this study.

Nucleotide sequence accession numbers {#Sec8}
-------------------------------------

The nucleotide sequences obtained in this study have been deposited to the NCBI database; GenBank accession numbers are listed in Additional file [1](#MOESM1){ref-type="media"}: Table S2.

Statistical analysis {#Sec9}
--------------------

The data were analyzed by chi-square test using the SPSS software (SPSS Inc., Chicago, IL, USA; version 17.0), and a *P*-value \< 0.05 was considered to indicate statistically significant differences.

Results {#Sec10}
=======

H~2~S-negative *Salmonella* isolates {#Sec11}
------------------------------------

During national surveillance of salmonellosis in 2005--2013 in China, 46 H~2~S-negative *Salmonella* isolates were identified among 2179 *Salmonella* strains from various sources. These strains were divided into 12 serovars: *S.* Gallinarum, *S.* Typhimurium, *S.* Choleraesuis, *S.* Paratyphi A, *S.* Meleagridis, *S.* Agona, *S.* Thompson, *S.* Enteritidis, *S.* Derby, *S.* Paratyphi B, *S.* Hadar, and *S.* Give (Fig. [1a](#Fig1){ref-type="fig"}). Among them, *S.* Gallinarum, *S.* Paratyphi A, *S.* Meleagridis, *S.* Agona, *S.* Thompson, *S.* Paratyphi B, *S.* Hadar, and *S.* Give were reported as having the non-H~2~S-producing phenotype for the first time. The most prevalent serovars for non-H~2~S-producing *Salmonella* were *S.* Gallinarum, *S.* Typhimurium, *S.* Choleraesuis and *S.* Paratyphi A, accounting for 33, 17, 13 and 13%, respectively, of the entire collection. Twenty-four (52%) samples were from humans with diarrhea, whereas 21 (46%) were from animals, including pork, chicken, and aquatic products, and one H~2~S-negative isolate was recovered from the river. During the period from 2006 to 2009, only three H~2~S-negative isolates were identified; however, approximately 93% isolates were identified with a high level of detection in the following 4 years (Fig. [1b](#Fig1){ref-type="fig"}).Fig. 1Distribution of non-H~2~S-producing *Salmonella* isolates in China by serotype (**a**) and time of isolation (**b**)

Antimicrobial resistance among H~2~S-negative *Salmonella* {#Sec12}
----------------------------------------------------------

Testing of the identified *Salmonella* isolates for antimicrobial susceptibility to 21 different antibiotics showed that they exhibited a high rate of resistance to conventional antimicrobial agents. H~2~S-negative isolates displayed high resistance to ampicillin, ticarcillin, tetracycline, tobramycin, chloramphenicol, gentamicin, and trimethoprim-sulfamethoxazole (Table [1](#Tab1){ref-type="table"}); furthermore, quinolone-resistant and cefazolin-resistant strains were also detected.Table 1Antibiotic resistance patterns for various serovars of H~2~S-negative *Salmonella* isolatesAntimicrobial drugsResistant isolates, % (n)Total (*n* = 46)Gallinarum (*n* = 15)Typhimurium (*n* = 8)Choleraesuis (*n* = 6)Meleagridis (*n* = 2)Derby (*n* = 1)Give (*n* = 1)Cefazidime0000000Ceftriaxone0000000Cefepime0000000Cefoperazone0000000Imipenem0000000Nitrofurantoin2 (1)013 (1)0000Piperacillin4 (2)013 (1)17 (1)000Ticarcillin46 (21)80 (12)50 (4)67 (4)00100 (1)Ticarcillin-clavulanic acid7 (3)6 (1)25 (2)0000Ampicillin46 (21)80 (12)50 (4)67 (4)00100 (1)Tetracycline35 (16)13 (2)63 (5)83 (5)100 (2)100 (1)100 (1)Cefazolin2 (1)7 (1)00000Cefoxitin000000Aztreonam000000Chloramphenicol15 (7)025 (2)50 (3)0100 (1)100 (1)Tobramycin2 (1)00000100 (1)Gentamicin13 (6)025 (2)50 (3)00100 (1)Amikacin0000000Trimethoprim-sulfamethoxazole24 (11)6 (1)25 (2)67 (4)100 (2)100 (1)100 (1)Norfloxacin4 (2)025 (2)0000Levofloxacin4 (2)025 (2)0000

Each serovar showed a distinct antibiotic resistance pattern (Table [1](#Tab1){ref-type="table"}). Overall, H~2~S-negative *S.* Typhimurium isolates demonstrated resistance to 11 antibiotics, with a high resistance rate to penicillins and tetracyclines. For two quinolones-resistant *S.* Typhimurium isolates, multisite mutations were detected simultaneously in the *gyrA* and *parC* genes; polymorphisms at positions 200 and 250 may be responsible for the resistance to quinolones (GenBank accession numbers: KY814731--KY814732 and KY814737--KY814738). H~2~S-negative *S.* Choleraesuis isolates displayed high resistance to tetracycline, ticarcillin, ampicillin, trimethoprim-sulfamethoxazole, chloramphenicol and gentamicin; importantly, all these isolates were from hospitalized diarrhea patients. About 80% of H~2~S-negative *S.* Gallinarum isolates were resistant to ticarcillin and ampicillin. In addition, H~2~S-negative *S.* Give, *S.* Derby, and *S.* Meleagridis were resistant to seven, three, and two antibiotics, respectively. All H~2~S-negative *S.* Paratyphi A, *S.* Paratyphi B, *S.* Enteritidis, *S.* Agona, *S.* Harder, and *S.* Thompson isolates were susceptible to the 21 tested antimicrobials.

Among the examined H~2~S-negative *Salmonella*, the MDR phenotype was observed in eight (17%) isolates (Table [2](#Tab2){ref-type="table"}). The H~2~S-negative MDR strains showed seven distinct antibiotic-resistance profiles. Two MDR isolates identified as H~2~S-negative *S.* Typhimurium had the widest antibiotic-resistance profiles, showing resistance to more than six classes of antimicrobials, including 11 individual antibiotics. H~2~S-negative *S.* Choleraesuis isolates displayed the highest MDR rate: 67% (4 of 6). Among them, one isolate was resistant to five classes of antimicrobials, and the others were resistant to four classes. Moreover, H~2~S-negative *S.* Give and *S.* Derby isolates also had the MDR phenotype. The same proportions of H~2~S-negative MDR isolates (about 50%) were recovered from humans and animals.Table 2Multidrug resistance profiles of eight H~2~S-negative MDR isolatesSerotypeNumber of isolatesAntibiotic resistance profilesAntimicrobial drug classesAminoglycosidesAmphenicolsFolate pathway inhibitorsNitrofuransPenicillinsQuinolonesTetracyclinesTyphimurium1GEN/CHL/SXT/NIT/AMP/TIC/TIM/LEV/NOR/TET+++++++Typhimurium1GEN/CHL/SXT/AMP/PIP/TIC/TIM/LEV/NOR/TET++++++Give1GEN/TOB/CHL/SXT/AMP/TIC/TET+++++Choleraesuis1GEN/CHL/SXT/AMP/PIP/TIC/TET+++++Choleraesuis2GEN/SXT/AMP/TIC/TET++++Choleraesuis1CHL/SXT/AMP/TIC/TET++++Derby1CHL/SXT/TET+++*AMP* ampicillin, *CHL* chloramphenicol, *GEN* gentamicin, *LEV* levofloxacin, *NIT* nitrofurantoin, *NOR* norfloxacin, *PIP* piperacillin, *SXT* trimethoprim/sulfamethoxazole, *TET* tetracycline, *TIC* ticarcillin, *TIM* ticarcillin/clavulanic acid, *TOB* tobramycin

PFGE and MLST analyses {#Sec13}
----------------------

H~2~S-positive *S.* Gallinarum, *S.* Hadar, *S.* Paratyphi A, *S.* Paratyphi B, *S.* Choleraesuis, and *S.* Give isolates were not detected during national surveillance for salmonellosis in this study. For PFGE testing and MLST analysis, we combined 46 H~2~S-negative and 29 H~2~S-positive *Salmonella* isolates (four *S.* Derby, seven *S.* Enteritidis, four *S.* Agona, three *S.* Thompson, two *S.* Meleagridis, and nine *S.* Typhimurium) to clarify their genetic relationships. Cluster analysis divided the 75 isolates into three distinct groups sharing approximately 50% similarity (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Dendrogram analysis based on the PFGE data for 75 *Salmonella* isolates. Strain number, serotype, origin, source, ST, and year of isolation are listed after each PFGE profile. Diamonds indicate strains isolated from the same sample

Group I consisted of four clusters. Cluster 1 contained two serovars: *S.* Derby and *S.* Enteritidis. *S.* Derby H~2~S-producing SH10SF170--1 and non-H~2~S-producing SH10SF170--2 had indistinguishable PFGE profiles, similar to *S.* Enteritidis SH11G52--1 and SH11G52--2. In cluster 2, all isolates were from poultry and were identified as H~2~S-negative *S.* Gallinarum. Although these strains were acquired from different places at different times, they shared high similarity in their PFGE patterns. All H~2~S-negative *S.* Gallinarum isolates belonged to ST92 except for one belonging to the new ST1961, which was a single locus variant (SLV) of ST92. Moreover, *S.* Agona H~2~S-negative isolates had PFGE profiles similar to those of H~2~S-positive strains, as well as to that of H~2~S-negative *S.* Thompson. *S.* Derby, *S.* Enteritidis, *S.* Agona, and *S.* Thompson belonged to ST40, ST11, ST13, and ST26, respectively.

In Group II, pairs of H~2~S-producing and -non-producing *S.* Meleagridis isolated from two samples were grouped in cluster 5; despite different sources, the two pairs had the same PFGE patterns and ST. Cluster 6 contained only one H~2~S-negative *S.* Hadar belonging to ST473. Cluster 7 was formed by six H~2~S-negative *S.* Paratyphi A and one H~2~S-negative *S.* Paratyphi B isolates. The six H~2~S-negative *S.* Paratyphi A isolates (four ST85 and two ST129) were from humans, andoneH~2~S-negative *S.* Paratyphi B belonging to ST42 was from an aquatic product. The six H~2~S-negative *S.* Choleraesuis isolates in cluster 8 had close PFGE patterns, the same ST, and were acquired from the same source and place. In cluster 9, pairs SH10SF298--1 and SH10SF298--2, SH12G945--1 and SH12G945--2, and SH12G1035--1 and SH12G1035--1 were from the same samples, respectively; each pair had very similar banding patterns. Among *S.* Typhimurium H~2~S-negative isolates, six were from humans: four ST34, one ST1544, and one ST19; the former two were SLVs of ST19 and double locus variants (DLVs) of each other.

Finally, Group III consisted of one H~2~S-negative *S.* Give isolate belonging to ST516.

Sequence analysis of the *Phs* operon {#Sec14}
-------------------------------------

Previous studies have reported mutations in the *phs* operon may responsible for the non-H~2~S-producing phenotype in *Salmonella* \[[@CR8], [@CR13]--[@CR15]\]*.* In the *phsA* gene, three different mutation sites were detected among the 46 H~2~S-negative *Salmonella* isolates (Table [3](#Tab3){ref-type="table"}). In *S.* Gallinarum isolates, missense mutation 1624C \> T leading to the Leu \> Phe substitution was found. In *S.* Choleraesuis isolates, single base deletion 760delG was detected, leading to a frameshift mutation. One H~2~S-negative *S.* Typhimurium (SH10G140) isolate had mutation 1087delA, which caused a frameshift and change in the amino acid sequence. Only few missense mutations were identified in H~2~S-negative *S.* Give and *S.* Hadar (data not shown). However, no mutations in the *phsA* gene were detected in the remaining 22 isolates (seven *S.* Typhimurium, six *S.* Paratyphi A, two *S.* Agona, two *S.* Meleagridis, two *S.* Thompson, one *S.* Paratyphi B, one *S.* Derby, and one *S.* Enteritidis).Table 3Mutations detected in the *phsA* gene of H~2~S-negative *Salmonella* isolatesSerotypeNumber of isolatesMutationMutation typeGallinarum15**1624C \> T**MissenseCholeraesuis6760delGFrameshiftTyphimurium1**1087delA**FrameshiftNew mutations are marked bold

In the *phsB* gene, we identified only one nonsense mutation in a *S.* Hadar isolate and multiple missense mutations in *S*. Gallinarum isolates. There were four main missense mutation sites, including substitutions 164 T \> C (eight isolates), 314G \> C (eight isolates), 319C \> A (11 isolates), and 373C \> T (eight isolates). In the *phsC* gene, nonsense and missense mutations were found in one H~2~S-negative *S.* Typhimurium and three H~2~S-negative *S.* Paratyphi A isolates, respectively (Additional file [1](#MOESM1){ref-type="media"}: Table S3).

Sixteen H~2~S-negative isolates carried no mutations in the *phs* locus (*phsA*, *phsB*, and *phsC* genes).

Discussion {#Sec15}
==========

Although there are few reports about H~2~S-negative *Salmonella*, the incidence of H~2~S-negative strains is on the rise lately. To the best of our knowledge, 100 H~2~S-negative *Salmonella* isolates of 13 serovars have been reported \[[@CR6]--[@CR12]\]. Moreover, 17 H~2~S-negative *S.* Senftenberg isolates, 19 H~2~S-negative *S.* Choleraesuis isolates, and seven H~2~S-negative *S.* Aberdeen isolates were reported in our previous studies \[[@CR13]--[@CR15]\]. In this study, a total of 46 H~2~S-negative *Salmonella* strains belonging to 12 various serovars were isolated from diverse sources across China during 2005--2013. H~2~S-negative *S.* Agona, *S.* Meleagridis, *S.* Gallinarum, *S.* Give, *S.* Hadar, *S.* Paratyphi A, *S.* Paratyphi B, and *S.* Thompson were newly identified, indicating that multiple *Salmonella* serovars could present the non-H~2~S-producing phenotype. Notably, our surveillance data revealed that 52% strains were isolated from diarrhea patients in hospitals, suggesting that H~2~S-negative *Salmonella* isolates, similar to H~2~S-positive strains, may play an important role in causing human infections. In addition, food products were another important source of H~2~S-negative *Salmonella* isolates. It has been reported that 33 *Salmonella* isolates were identified as H~2~S-negative in 82 retail meat samples from markets in Shenzhen, China \[[@CR10]\]. In this study, about 46% H~2~S-negative *Salmonella* isolates were from pork, chicken, and aquatic products, suggesting that H~2~S-negative *Salmonella* could be present in various foods. Since *Salmonella* isolation methods vary among laboratories and hospitals from different locations, it is possible that the number of H~2~S-negative isolates could be higher than that reported here. Therefore, proposing a standard screening procedure will reduce the missing H~2~S-negative *Salmonella* during laboratory and hospital screening*.* In addition, we recommend using API 20E biochemical test kits and serological testing to further confirm the suspected H~2~S-negative colonies when necessary.

Although a large number of H~2~S-negative *Salmonella* strains have been reported, their antibiotic resistance patterns were not clarified. Among the H~2~S-negative *Salmonella* identified in this study, *S.* Choleraesuis exhibited a high rate of antibiotic resistance, comprising 67% of MDR isolates; similar data on the MDR rate among H~2~S-negative *S.* Choleraesuis isolates were reported in Japan and in our previous study \[[@CR7], [@CR14]\]. To the best of our knowledge, MDR has been previously detected only in H~2~S-negative *S.* Choleraesuis and *S.* Kentucky \[[@CR6], [@CR7]\]. In this study, the MDR phenotype was observed among H~2~S-negative *S.* Typhimurium, *S.* Give, and *S.* Derby isolates, which were resistant to 11, seven, and three antibiotics, respectively. In addition, amino acid changes in the GyrA and ParC proteins have been detected in the ciprofloxacin-resistant H~2~S-negative *S.* Kentucky strain and norfloxacin-resistant H~2~S-negative*S.* Choleraesuis strains \[[@CR6]\]. In this study, we detected mutations in the *gyrA* and *parC* genes of H~2~S-negative *S.* Typhimurium strains with complete resistance to quinolones. Cumulatively, these results suggest that the emergence of antibiotic resistance among H~2~S-negative *Salmonella* strains presents a more serious problem than has been previously anticipated. Although the mechanism of H~2~S-mediated antibiotic resistance has been demonstrate in several bacteria, this process requires anaerobic conditions and antibiotics which have to exert their bactericidal effect by oxidative stress \[[@CR20], [@CR23], [@CR28]\]. What's more, plasmid-mediated drug resistance mechanism is responsible for the increased resistance rate to antibiotics as well. Hence, there is a great need to take effective measures to control the prevalence of H~2~S-negative *Salmonella* isolates with MDR.

Disruption of the *phsA* gene seems to underlie the lack of H~2~S production in a large number of H~2~S-negative *Salmonella* isolates, although mutation analysis was not conducted for all reported H~2~S-negative *Salmonella* \[[@CR8], [@CR13]--[@CR15]\]. H~2~S-negative *S.* Typhimurium and *S.* Infantis have been reported to contain nonsense mutations at positions 1440 and 358 of the *phsA* gene, respectively \[[@CR8]\]. Previously, we identified a frameshift mutation in H~2~S-negative *S.* Choleraesuis and nonsense mutations in H~2~S-negative *S.* Aberdeen and *S.* Senftenberg \[[@CR13]--[@CR15]\]. In this study, 22 (48%) H~2~S-negative *Salmonella* isolates carried mutations at different positions of the *phsA* gene, indicating that this gene may be responsible for the atypical H~2~S phenotype. Moreover, we found that *phsA* mutation sites were serovar-specific, suggesting that serovars containing H~2~S-negative isolates have distinct genetic mechanisms leading to mutations in the *phs* locus. As the *phs* operon is essential for the production of H~2~S from thiosulfate under anaerobic conditions, thiosulfate would concentrate around H~2~S-negative *Salmonella* cells and react with oxygen species generated during inflammation, producing a new respiratory electron acceptor tetrathionate \[[@CR29]--[@CR32]\]. These studies suggest that the accumulation of thiosulfate by H~2~S-negative *Salmonella* strains, including *S.* Typhimurium, may provide these strains a growth advantage in competition with other bacteria in the gut lumen, thus presenting a reasonable explanation for the large number of H~2~S-negative *Salmonella* isolates with high rate of antibiotic resistance detected in humans.

Conclusion {#Sec16}
==========

We identified 46 H~2~S-negative *Salmonella* isolates belonging to 12 serovars in China. As the number of these *Salmonella* strains has been rapidly increasing over a short period of 9 years, the emergence and prevalence of H~2~S-negative *Salmonella* cannot be ignored, and special attention should be paid to avoid their further dissemination by implementing specific surveillance measures.
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===============

 {#Sec17}

Additional file 1:**Table S1.** Reference strains for *phs* operon sequence analysis. **Table S2.** GenBank accession numbers for *phs* operon sequences from 46 H~2~S-negative *Salmonella* isolates. **Table S3.** Mutations detected in the *phsB* and *phsC* genes of H~2~S-negative *Salmonella* isolates. (DOC 71 kb)
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